While considerable advances have been made in understanding the biology and treatment of schizophrenia, patients and physicians continue to face tough challenges, says the 2015-16 winner of the University of Pennsylvania ...
May 19, 2016
0
44
It has been called a pioneering strategy for treating opioid addiction, and has already been adopted in a small yet growing number of jails and prisons in the United States. Now, a clinical trial published in the journal ...
Apr 14, 2015
0
53
Children treated for moderate acute malnutrition—a condition suffered by an estimated 35 million children worldwide—experience a disturbingly high rate of relapse and even death in the year following treatment and recovery.
Feb 11, 2015
0
12
In patients with neuromyelitis optica spectrum disorder (NMOSD, an autoimmune inflammatory disease of the central nervous system similar to multiple sclerosis but even more debilitating), the immunosuppressant medication ...
Sep 8, 2014
0
0
(HealthDay)—A smartphone application, or "app," designed to tackle addiction has helped recovering alcoholics stay sober or reduce their risky drinking, a new clinical trial reports.
Mar 26, 2014
0
0
The addition of a monoclonal antibody called gemtuzumab combined with standard chemotherapy has been shown to significantly reduce the risk of relapse and increase rates of disease-free survival in pediatric patients with ...
Dec 8, 2013
0
0
Among anesthesiology residents entering primary training from 1975 to 2009, 0.86 percent had a confirmed substance use disorder during training, with the incidence of this disorder increasing over the study period and the ...
Dec 3, 2013
0
0
About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder (MDD) have greater difficulty quitting.
Sep 16, 2013
0
0
Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports. As many as 96% of men ...
Aug 16, 2013
0
0
(HealthDay)—A patient with Crohn's disease is concerned about the attempt by the makers of adalimumab to prevent disclosure of trial data submitted during the drug's approval process, according to a personal view piece ...
Apr 18, 2013
0
0
